生命科学资讯

A pancreatic cancer approval; Seres cuts staff

Even Europeans don't see a future in Euro biopharma anymore

Terray says its AI model beats Boltz-2 at binding affinity prediction

Lyell starts first head-to-head CAR-T therapy trial

BridgeBio's dwarfism drug succeeds in Phase 3, adding to recent late-stage wins

European VCs form coalition to get more support for biotech investing

Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO

Hinge Health is looking to build AI tools for mental health support

FDA may consider Moderna's flu vaccine in a narrower group

Former AstraZeneca senior staff charged with illegal trade in China

Prasad overruled vaccine review team, office director on Moderna flu shot

After CEO departs, CSL details profit crash, $1.1B impairment costs

Madrigal pads MASH pipeline with six siRNAs from China's Ribo

Gubra forms venture unit; Galecto's $275M offering

How a closet full of EKG machines illustrates pharma’s clinical trial cost problem

Oscar Health expects explosive growth for 2026, but it comes with a risk

Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point?

Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial

Moderna accuses FDA of shifting standard as agency refuses flu shot review

Isomorphic claims major advance with new AI drug design engine